Related Experiment Video
Updated: Jun 8, 2026

10:02
Identification of Protein Interacting Partners Using Tandem Affinity Purification
Published on: February 25, 2012
37.5K
Fragment-Based Interrogation of the 14-3-3/TAZ Protein-Protein Interaction.
Blaž Andlovic1,2, Dario Valenti2,3, Federica Centorrino2
1Lead Discovery Center GmbH, Otto-Hahn-Str. 15, 44227 Dortmund, Germany.
Biochemistry
|August 22, 2024
Summary
Researchers identified a novel molecular glue that stabilizes interactions involving the 14-3-3 protein. This discovery offers a new chemical starting point for developing targeted therapies by stabilizing protein-protein interactions.
Area of Science:
- Biochemistry
- Structural Biology
- Drug Discovery
Background:
- Developing molecular glues to modulate protein-protein interactions (PPIs) is challenging.
- The 14-3-3 protein family plays crucial roles in various cellular signaling pathways.
- Targeting 14-3-3 mediated PPIs presents therapeutic opportunities.
Purpose of the Study:
- To identify chemical starting points for molecular glue development targeting 14-3-3 protein interactions.
- To characterize a novel allosteric stabilizer of the 14-3-3/TAZ peptide complex.
Main Methods:
- Fragment screening was employed to identify potential binders.
- Differential scanning fluorimetry and microscale thermophoresis were used to assess stabilization.
- Molecular dynamics, nuclear magnetic resonance, and X-ray crystallography were utilized to determine the binding site.
Main Results:
- A fragment was identified that preferentially binds to the 14-3-3/TAZ peptide complex.
- The fragment demonstrated moderate stabilization of the complex.
- Structural studies revealed an allosteric binding site between helices 8 and 9 of 14-3-3, distinct from the peptide interface.
Conclusions:
- This study presents the first example of an allosteric stabilizer for 14-3-3 protein-protein interactions.
- The identified fragment serves as a valuable chemical starting point for developing novel molecular glues.
- This work opens new avenues for modulating 14-3-3 mediated signaling pathways through allosteric stabilization.

